EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and outcomes of primary bedaquiline resistance in adults with rifampicin-resistant pulmonary tuberculosis

Peter G Beckwith, James C M Brust, Graeme Meintjes, Shaheed V Omar, Julian te Riele, Norbert Ndjeka, Gary Maartens

Open Forum Infectious Diseases · 05.11.2026

DOI: 10.1093/ofid/ofag715 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 05.11.2026. Verfasst von Peter G Beckwith und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bedaquiline resistance (BDQ-R) is increasing worldwide, but the contribution of primary BDQ-R remains unclear in countries with a high burden of RR-TB and widespread bedaquiline use. We aimed to estimate the prevalence of primary BDQ-R and to describe treatment outcomes amongst adults with primary BDQ-R in the Western Cape province, South Africa.

Methods

We conducted a retrospective cohort study of patients with BDQ-R identified through routine phenotypic bedaquiline susceptibility testing. Among patients with baseline BDQ-R (defined as resistance detected in those on no RR-TB treatment or with <1 month of treatment exposure), BDQ-R was categorised as primary (no prior bedaquiline exposure) or acquired (prior bedaquiline exposure). Drug resistance profiles, treatment outcomes, and time to culture conversion were analysed.

Results

Among 146 patients with baseline BDQ-R, 81 (55%) had primary BDQ-R. Resistance to other RR-TB drugs was common (except for linezolid). Of 80 patients with baseline BDQ-R and a treatment outcome, 28 (35%) died at a median of 276 days (IQR 129–459) after BDQ-R diagnosis. 117/136 (86%) achieved sputum culture conversion in a median of 97 days (IQR 89 –116). Acquired BDQ-R was associated with a lower hazard of culture conversion (adjusted HR: 0.37; p<0.001) and fewer favourable treatment outcomes (12.5% vs 47.9%; P=0.001) than primary BDQ-R.

Conclusion

Over half of BDQ-R cases were due to primary transmission. Outcomes were poor, but better in primary than acquired BDQ-R. Optimized susceptibility testing and treatment strategies are urgently needed to limit BDQ-R transmission.

Zitieren

APA

Beckwith, P. G., Brust, J. C. M., Meintjes, G., Omar, S. V., Riele, J. T., Ndjeka, N., & Maartens, G. (2026). Prevalence and outcomes of primary bedaquiline resistance in adults with rifampicin-resistant pulmonary tuberculosis. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag715

Vancouver

Beckwith PG, Brust JCM, Meintjes G, Omar SV, Riele JT, Ndjeka N, et al. Prevalence and outcomes of primary bedaquiline resistance in adults with rifampicin-resistant pulmonary tuberculosis. Open Forum Infectious Diseases. 2026. doi:10.1093/ofid/ofag715

BibTeX
@article{Beckwith2026,
  author = {Beckwith, Peter G and Brust, James C M and Meintjes, Graeme and Omar, Shaheed V and Riele, Julian te and Ndjeka, Norbert and Maartens, Gary},
  title = {Prevalence and outcomes of primary bedaquiline resistance in adults with rifampicin-resistant pulmonary tuberculosis},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  doi = {10.1093/ofid/ofag715}
}
Kostenlos starten →